SCI投稿信件的一些套话
Please acknowledge receipt of this e-mail
Response to reviewers
reviewer 1
question 1 ...XX.........
answer:......... (pageXX, LineXX )
文字修改
*******（原来的意见）
corrected ******（(pageXX, LineXX )）
就是让他一眼就看出来你改了，在那里？如何改的
投稿: contribution, paper contribution from P. R. China
Notification of Acceptance / Rejection
ACCEPTANCE LETTER
投稿信
1. Dear Dr. Defendi ML:
I am sending a manuscript entitled ―‖ by – which I should like to submit for possible publication in the journal of - .
Yours sincerely
2. Dear Dr. A:
Enclosed is a manuscript entitled ―‖ by sb, which we are submitting for publication in the journal of - . We have chosen this journal because it deals with - . We believe that
sth would be of interest to the journal’s readers.
3. Dear Dr. A:
Please find enclosed for your review an original research article, ―‖ by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source.
We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers.
二、询问有无收到稿件
Dear Editors,
We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help.
三、询问论文审查回音
Dear Editors,
Sorry for disturbing you. It is more than 25 weeks since I submitted our manuscript entitled ―TCF BLEACHING OF EUCALYPTUS UROPHYLLA×EUCALYPTUS GRANDIS LH 107 OXYGEN DELIGNIFIED KRAFT PULP—PARTIAL Mg2+/Ca2+ SUBSTITUTION FOR CHELANTS‖by post on a CD for possible publication in your journal ―Cellulose Chemistry and Technology‖. I have not yet received a reply
and am wondering whether you have reached a decision. I should appreciate your letting me know what you have decided as soon as possible. Thank you in advance for your help. Attached please find the word version of my paper entitled "TCF BLEACHING OF EUCALYPTUS UROPHYLLA×EUCALYPTUS GRANDIS LH 107 OXYGEN DELIGNIFIED KRAFT PULP—PARTIAL Mg2+/Ca2+ SUBSTITUTION FOR CHELANTS" with the kind request to consider it for publication in the journal Cellulose Chemistry and Technology.
Best Regards,
Sincerely,
Xue-Fei Zhou
Dear Cristina Irimia,
Sorry for disturbing you. It is more than 3 weeks since I submitted our revised manuscript (No. 4387) for possible publication in your journal Cellulose Chemistry and Technology. I have not yet received a ACCEPTANCE LETTER by e-mail and I am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible.
Best Regards,
Sincerely,
Xue-Fei Zhou
四、关于论文的总体审查意见
1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below.
2. This is a well-written paper containing interesting results which merit publication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below.
3. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in PNAS. We suggest that the authors try submitting their findings to specialist journal such as –
4. Although this paper is good, it would be ever better if some extra data were added.
5. This manuscript is not suitable for publication in the journal of – because the main observation it describe was reported 3 years ago in a reputable journal of - .
6. Please ask someone familiar with English language to help you rewrite this paper. As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory.
7. We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a good knowledge of English, preferable native speaker.
8. The wording and style of some section, particularly those concerning HPLC, need careful editing. Attention should be paid to the wording of those parts of the Discussion of and Summary which have been underlined.
9. Preliminary experiments only have been done and with exception of that summarized in Table 2, none has been repeated. This is clearly unsatisfactory, particularly when there is so much variation between assays.
10. The condition of incubation are poorly defined. What is the temperature? Were antibody used?
五、给编辑的回信
1. In r eply to the referee’s main criticism of paper, it is possible to say that –
One minor point raised by the referee concerns of the extra composition of the reaction mixture in Figure 1. This has now been corrected. Further minor changes had been made on page 3, paragraph 1 (line 3-8) and 2 (line 6-11). These do not affect our interpretation of the result.
2. I have read the referee’s comments very carefully and conclude that the paper has been rejected on the sole grounds that it lake toxicity data. I admit that I did not
include a toxicity table in my article although perhaps I should have done. This was for the sake of brevity rather than an error or omission.
3. Thank you for your letter of –and for the referee’s comments concerning our manuscript entitle d ―‖. We have studied their comments carefully and have made correction which we hope meet with their approval.
4.
Dear Ms. Parisa Morovati,
Thanks for your kind help in this matter.
I enclosed a sole submission form and a potential reviewers.
Sincerely Yours,
Xue-Fei Zhou
I enclosed a revised manuscript which includes a report of additional experiments done at the referee’s suggestion. You will see that our original findings are confirmed.
5. We are sending the revised manuscript according to the comments of the reviewers. Revised portion are underlined in red.
6. We found the referee’s comments most helpful and have revised the manuscript
7. We are pleased to note the favorable comments of reviewers in their opening sentence.
8. Thank you for your letter. I am very pleased to learn that our manuscript is acceptable for publication in Cancer Research with minor revision.
9. We have therefore completed a further series of experiments, the result of which are summarized in Table 5. From this we conclude that intrinsic factor is not account.
10. We deleted the relevant passage since they are not essential to the contents of the paper.
11. I feel that the reviewer’s comments concerning Figures 1 and 2 result from a
misinterpretation of the data.
12. We would have include a non-protein inhibitor in our system, as a control, if one had been available.
13. We prefer to retain the use of Table 4 for reasons that it should be clear from the new paragraph inserted at the end of the Results section.
14. Although reviewer does not consider it is important to measure the temperature of the cells, we consider it essential.
15. The running title has been changed to ―‖.
16. The Materials and Methods section now includes details for measuring uptake of isotope and assaying hexokinase.
17. The concentration of HAT media (page12 paragraph 2) was incorrectly stated in the original manuscript. This has been rectified. The authors are grateful to the referees for pointing out their error.
18. As suggested by both referees, a discussion of the possibility of laser action on chromosome has been included (page16, paragraph 2).
19. We included a new set of photographs with better definition than those originally submitted and to which a scale has been added.
20. Following the suggestion of the referees, we have redraw Figure 3 and 4.
21. Two further papers, published since our original submission, have been added to the text and Reference section. These are:
22. We should like to thank the referees for their helpful comments and hope that we have now produced a more balance and better account of our work. We trust that the revised manuscript is acceptable for publication.
23. I greatly appreciate both your help and that of the referees concerning improvement to this paper. I hope that the revised manuscript is now suitable for publication.
24. I should like to express my appreciation to you and the referees for suggesting how to improve our paper.
25. I apologize for the delay in revising the manuscript. This was due to our doing an additional experiment, as suggested by referees.
第一步：了解在线投稿系统
1，所有的美国化学学会的期刊都可以使用在线投稿系统来投稿。
2，美国化学学会的在线投稿系统已经从2006年开始升级，将由原来的ACS Paragon系统升级到ACS Paragon Plus系统。详情见：
https://www.doczj.com/doc/ef13643002.html,/paragonplus/splash/index.html
3，目前，只有《Journal of Chemical Theory and Computation》在使用ACS Paragon Plus系统，其它期刊仍使用ACS Paragon系统，地址为：
https://https://www.doczj.com/doc/ef13643002.html,/paragon/index.jsp
第二步：使用在线投稿系统
1，注册一个帐号，以后所有的操作，此在线投稿系统都会给你的邮箱地址发送一封确认信。
2，从在线投稿系统下载投稿模版，将自己的稿件重新排版。
3，根据在线投稿系统的提示来投稿。
4，投稿完成以后，系统会发一封确认信到你的邮箱。
5，如果你上传的稿件和cover letter 是word格式，投稿系统会自动将它转换为pdf格式。
6，投稿结束前，系统会提醒你在核查一次。
7，你可以替别人（通讯联系人）投稿，但是以后所有相关信件会发送至通讯联系人的邮箱。
第三步：等待编辑部的处理
1，投稿结束后，系统会发送确认信到你的邮箱，并给你的稿件编号，比如《INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH》期刊的编号是
iexxxxxxx，前2位表示期刊，后7位为文章编号。
2，通常在投稿的第二天，编辑部会给你发送一份处理信，告诉你文章是被拒收了，还是给你指定编辑了。这其实就是编辑部的初审。
3，文章被拒的话，通常是因为内容的缘故，不过大家在投稿的时候，还是该注意一下文章版面的编辑。
4，如果文章初审通过，编辑部会给你的文章指定一位编辑，以后，所有的有关此稿件的联系请直接与指定编辑联系。
5，另外，编辑部还会要求你填写一份copyright form并传真给指定的编辑。此表格可以从投稿系统的网站上下载，有2种格式，大家最好使用交互式的文件格式，添好后打印出来签字，可以传真，也可以使用电子邮件发送给编辑。
6，参考邮件（全是我的真实邮件，略去了文章编号，编辑的联系方式和一些个人信息）：
邮件标题：Manuscript ieXXXXXXX assignment
正文：
Dear Dr.XX:
Your manuscript ieXXXXXXX, entitled "XXXX", has been assigned to the following Industrial & Engineering Chemistry Research Editor:
XX
Email: XX
Mailing Address:
I&EC Research, Dept. of Chemical Engr.
Carnegie Mellon University
5000 Forbes Avenue, DH2208E
Pittsburgh, PA 15213
USA
Fax: 1-412-268-8694
PLEASE ADDRESS ALL FUTURE CORRESPONDENCE REGARDING THIS MANUSCRIPT TO THE ABOVE EDITOR.
In our instructions for Web submissions, we ask that you include in your cover letter names and complete addresses of several individuals who would be qualified to review your manuscript. Please send these by e-mail to the editor at the above address as soon as possible so that we can begin processing your manuscript.
IMPORTANT NOTE: Please fax your completed and signed copyright form to the editor at the above fax number immediately.
The form can be found on the web at: https://https://www.doczj.com/doc/ef13643002.html,/paragon/ ...
list/copyright.pdf. If you have hardcopy supporting information or permissions correspondence or forms (https://www.doczj.com/doc/ef13643002.html,/instruct/permform.pdf), please mail or fax these along with your copyright form to the editor's office.
Submission of a manuscript to Industrial & Engineering Chemistry Research implies that the work reported therein has not received prior publication and is not under consideration for publication elsewhere in any medium, including electronic journals and computer databases of a public nature. This manuscript is being considered with the understanding that it is submitted on an exclusive basis. If otherwise, please advise.
补充：
1，cover letter的写作：在线投稿的时候需要提交一次，第一次和编辑联系的时候（也就是向编辑提交copyright form的时候），可以直接写在正文里。具体内容，小木虫上已经有很多模版了，写起来也很方便。我本人就是借用了一个模版自己改写了的。
2，常常要登录自己的投稿系统，追踪文章状态。投稿刚结束后，Submitted to Editorial Office下No Action Required模块中的Number为文章编号，Journal为投稿期刊，Title为稿件名称，Submission Date为投稿日期。但是，Editor和Revision
为空。等到文章被指定编辑后，Editor下就会显示编辑的姓名。Revision表示需要修改，是第一次修改，显示为1，是第二次修改，则显示2。投完修改稿以后，会发现Number，Journal，Title，Editor显示到Revisions Required by Editorial Office 模块下，Requested Date为提出修改的日期。
第四步：询问文章处理情况
1，国外文章都是通过电子邮件送审，通常都比较快。但是如果你没有指定审稿人的话，可能稿件处理的要慢一些，因为编辑未必熟悉你的这个领域，由编辑自己选择审稿人，可能在这个过程中，有的审稿人提出不能审稿，于是又要更换审稿人，从而延长了稿件处理周期。
2，参考邮件：
我写给编辑的信：
邮件主题：Is my manuscript ieXXXXXXX under processing?
正文：
Dear Professor XX
Thank you very much for your attention to my letter.
I'm a PhD student of XX, I have submitted a manuscript ieXXXXXXX, entitled "XX" on August 15 2005 on the web at https://https://www.doczj.com/doc/ef13643002.html,. Because I submit my manuscript to IE&C for the first time, so I can not offer individuals who would be qualified to review my manuscript. There are two months so far, I want to know whether my manuscript is under reviewing. If my manuscript isn't sent to any reviewer because I do not offer reviewers, I will send names and complete addresses of several individuals who would be qualified to review my manuscript to you immediately.
Thank you very much for your considering my manuscript. I'm looking forward to
hearing from you soon.
Best wishes.
对方的回信：
Dear Dr. XX,
We sent your manuscript, ieXXXXXXX, out for review on August 29, 2005. Despite reminder letters, we still have not received a response from the reviewers. If you know of other qualified reviewers, please send us their
names and email addresses.
Thank you.
3，从回信中可看出，即使我没有提供审稿人，对方还是比较及时地将稿件送审了，而且对方也催了审稿人。我后来也就没有再推荐审稿人了，不过这次审稿时间有点长，如果大家有合适的审稿人，还是自己推荐的好，我是找不到合适的审稿人才没有推荐的。
4，与编辑之间的联系，都不是编辑本人回复的，全是编辑的助手在代劳。
第五步：修改稿件并使用在线投稿系统投出
1，编辑会在收到审稿人的意见后，及时地告诉你审稿人的意见，并告诉你是退稿，还是修改。
2，参考邮件
邮件主题：Revision Requested for ieXXXXXXX
正文：
December 5, 2005
Dear Dr. XX:
We are requesting that you revise your manuscript. When submitting your
revised manuscript, please include in the file with the cover letter an itemized list of changes to your manuscript, along with a response to the reviewers' comments. Please make the changes requested on the Copy Revision Form.
TO REVISE YOUR MANUSCRIPT ON THE WEB:
-------------------------------------
NOTE: Please submit your revision using your Paragon home page.
1. Log on to your Paragon home page at https://www.doczj.com/doc/ef13643002.html,.
2. Scroll to the section titled: 'Revisions required by
Editorial Office.'
- Click on the manuscript number* to submit a revision.
3. Follow the directions in Paragon to complete the submission
of your revision.
[* In the event this manuscript is not listed on your home page:
- Click on the 'Revise Manuscript' button to add the
manuscript to your home page and revise the manuscript
- Enter the manuscript number and security key as follows:
Manuscript Number: ieXXXXXXX
NOTE: All manuscript numbers begin with the letters
'ie' followed by 6 numbers. The last
character can be either a letter, a number,
or a '+' sign.
Security Key: XXXXXX
- Click on "Add Paper"
- The manuscript should now appear in the
'Revisions required by Editorial Office' section
Continue with steps 2 and 3 above. ]
3，修改稿件时，要对审稿人的每条意见进行回复。
4，来信中会告诉你一个帐号密码，如果你是在线投稿，根本就用不上。这是给其它方式投稿用的，比如你邮寄稿件过去，后来想用在线投稿系统修改。
第六步：文章录用通知
1，一篇稿件不一定只改一次，我的文章就改了2次。
2，通常会在投完修改稿的一周内，编辑部给出录用通知。如果一周内还没有得到编辑部的回复，很可能是稿件又送出去审了。
3，发送录用通知的邮件是由编辑亲自写的，不是助手代劳了，信中会告诉你一些注意事项。
4，登录在线投稿系统，Number，Journal，Title，Editor会显示到In Production 下的No Action Required模块中，Proj. Issue为预期出版期数，Target Date预期出版日期。
5，此时，只需要等待出版社通知你校稿了，与编辑的联系已经结束，你可以写份感谢信。
6，参考邮件：
邮件主题：Final status notification for manuscript ieXXXXXXX
正文：
Dear Dr. XX:
We are pleased to inform you that your manuscript entitled "XX" (manuscript ID ieXXXXXXX) has been accepted for publication in Industrial & Engineering Chemistry Research. Your manuscript has been forwarded to the ACS Publications office.
You will be contacted in the near future by the ACS Journal Publishing Staff
regarding the page proofs for your manuscript. Your paper will be published on the Web approximately 48 hours after you approve your page proofs. In view of this fast publication time it is important to review your page proofs carefully. Once a manuscript appears on the web it is published. Any change after that point must be considered additions / corrections.
第七步：文章校稿
1，通常会在一个月内，出版社会发邮件告诉你可以较稿了，并给出帐号和密码。也可以使用在线投稿系统，利用这个帐号和密码去校稿。
2，校稿结束后，系统会给你的邮箱发送一封确认信，并显示你的校稿意见。3，提交完校稿意见后，在2-5天内，你的文章便成为ASAP文章。即很快见刊。4，参考邮件：
邮件主题：Galley proof of ieXXXXXXX available for review
正文：
Dear Li Jun:
The proof of your paper, manuscript number ieXXXXXXX, entitled
XX
is now available electronically for your review and approval at
the following URL:
https://www.doczj.com/doc/ef13643002.html,/galleys/egalley.html
At this URL you will be prompted to enter:
Manuscript number: ieXXXXXXX
Security Key: XXXXXX
You will then go to a site where you will be able to view and
download PDF files containing:
1. Instructions for review and submission of corrections/approval
for your paper.
2. A Reprint Order Form.
3. The proof of your paper as it will appear in Industrial & Engineering Chemistry Research.
4. The text of your accepted manuscript with all editing changes
indicated.
5. Information regarding the distribution of 50 free electronic
reprints of your paper during the first year following online
publication in the Industrial & Engineering Chemistry Research Web Edition, and unlimited
electronic reprints after year one.
Thank you for publishing in Industrial & Engineering Chemistry Research.
第八步：文章出版
1，美国化学学会的文章先在网上发行，然后是印刷型的，文章出版后，对方会告诉你这篇文章的网络版地址已经帐号密码。
2，校稿越快越好，可以提前出版。我的文章预期是第9期，结果我当天就校完稿，后来在第8期就出版了。
3，参考邮件：
邮件主题：Web access to I&ECR
正文：
Dear Dr. XX:
In case you have not seen it, your paper has been published in Number X,
Volume XX of Industrial & Engineering Chemistry Research. On behalf of my colleagues, I want to thank you for this contribution to our journal.
As a courtesy, we have arranged for you to have access to the web edition
of the issue in which your article appears in case you or your organization
are not subscribers. You may see this issue by contacting the URL
https://www.doczj.com/doc/ef13643002.html,/iecr, clicking on an article in the Index,
and entering the code when prompted. Your code for both User-ID and
Password is XXXXXXX.
You may forward this information to your co-authors to give them access also.
You may use this web site to learn more about our journal including how to subscribe.
Again, thanks for your contribution.
到此为止，文章就算发表了，记得给编辑写封感谢信。
来源: https://www.doczj.com/doc/ef13643002.html,/bbs/viewthread.php?tid=238114&fpage=1
lfang
2007-1-18 15:24:54
提交完校稿意见后，网上刊登出电子版以前，在ACS系统中论文的状态依然是Review Galley还是别的什么？
有经验的提供一点信息，谢谢。
lfang
2007-1-18 15:25:18
提交完校稿意见后，网上刊登出电子版以前，在ACS系统中论文的状态依然是Review Galley还是别的什么？
有经验的提供一点信息，谢谢。
一、最初投稿Cover letter Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”. The following is a list of possible reviewers for your consideration: 1) Name A E-mail: ××××@×××× 2) Name B E-mail: ××××@×××× We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address below. Thank you and best regards. Yours sincerely, ×××××× Corresponding author: Name: ××× E-mail: ××××@×××× 二、催稿信 Dear Prof. ×××: Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript has been sent to reviewers or not?
英文投稿中有关信件的写法 一、投稿信 1. Dear Dr. Defendi ML: I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of - . Yours sincerely 2. Dear Dr. A: Enclosed is a manuscript entitled “” by sb, which we are submitting for pu blication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers. 3. Dear Dr. A: Please find enclosed for your review an original research article, “” by sb. All author s have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source. We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. 二、询问有无收到稿件 Dear Editors, We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help. 三、询问论文审查回音 Dear Editors， It is more than 12 weeks since I submitted our manuscript (No: ) for possible publication in your journal. I have not yet received a reply and am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible. 四、关于论文的总体审查意见 1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below. 2. This is a well-written paper containing interesting results which merit p ublication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below. 3. Although these observation are interesting, they are rather limited and do not advance our
英文论文投稿信Cover letter模板 qiusuo BY - 2006-1-17 8:59:00 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a
(一)投稿前准备工作和需要注意的事项、投稿过程相关经验总结 投稿前准备工作和需要注意的事项： 总结提示语：1)第一作者和通信作者的区别： 通信作者(Corresponding author)通常是实际统筹处理投稿和承担答复审稿意见等工作的主导者，也常是稿件所涉及研究工作的负责人。 通信作者的姓名多位列于论文作者名单的最后(使用符号来标识说明是Corresponding author)，但其贡献不亚于论文的第一作者。 通讯作者往往指课题的总负责人，负责与编辑部的一切通信联系和接受读者的咨询等。 文章的成果是属于通讯作者的，说明思路是通讯作者的，而不是第一作者。 第一作者仅代表是你做的，且是最主要的参与者! 通信作者标注名称：Corresponding author，To whom correspondence should be addressed,或The person to whom inquiries regarding the paper should be addressed
若两个以上的作者在地位上是相同的，可以采取“共同第一作者”(joint first author)的署名方式，并说明These authors contributed equally to the work。 2)作者地址的标署： 尽可能地给出详细通讯地址，邮政编码。有二位或多位作者，则每一不同的地址应按之中出现的先后顺序列出，并以相应上标符号的形式列出与相应作者的关系。 如果第一作者不是通讯作者，作者应该按期刊的相关规定表达，并提前告诉编辑。期刊大部分以星号(*)、脚注或者致谢形式标注通讯联系人。 3)挑选审稿人的几个途径： 很多SCI杂志都需要作者自己提出该篇论文的和您研究领域相关的审稿人，比较常见的是三名左右，也有的杂志要求5-8人。介绍几个方法： ①利用SCI、SSCI、A&HCI、ISTP检索和您研究相关的科学家; ②文章中的参考文献; ③相关期刊编委或学术会议的主席、委员;
一、投稿信 1. Dear Dr. Defendi ML: I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of - . Yours sincerely 2. Dear Dr. A: Enclosed is a manuscript entitled “” by sb, which we are submitting for pub lication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers. 3. Dear Dr. A: Please find enclosed for your review an original research article, “” by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source. We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. 二、询问有无收到稿件 Dear Editors, We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help. 三、询问论文审查回音 Dear Editors， It is more than 12 weeks since I submitted our manuscript (No: ) for possible publication in your journal. I have not yet received a reply and am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible. 四、关于论文的总体审查意见 1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below. 2. This is a well-written paper containing interesting results which merit publication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below. 3. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in PNAS. We suggest that the authors try submitting their findings to specialist journal such as – 4. Although this paper is good, it would be ever better if some extra data were added. 5. This manuscript is not suitable for publication in the journal of –because the main observation it describe was reported 3 years ago in a reputable journal of - . 6. Please ask someone familiar with English language to help you rewrite this paper. As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory. 7. We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a
[zz] SCI 投稿全过程信件模板一览 SCI 投稿全过程信件模板一览(zz;比较过时,部分可参考) 一、最初投稿 Cover letterDear Editors:We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed.In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”.The following is a list of possible reviewers for your consideration:1) Name A E-mail: ××××@××××2) Name B E-mail: ××××@××××We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address below.Thank you and best regards.Yours sincerely,××××××Corresponding author: Name: ×××E-mail: ××××@×××× 二、催稿信 Dear Prof. ×××: Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID:文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript has been sent to reviewers or not?I would be greatly appreciated if you could spend some of your time check the status for us. I am very pleased to hear from you on the reviewer’s comments.Thank you very much for your consideration. Best regards! Yours sincerely,××××××
Please do not adjust margins Please do not adjust margins Address here. Address here. Address here. ? Footnotes relating to the title and/or authors should appear here. Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/x0xx00000x Received 00th January 20xx, Accepted 00th January 20xx DOI: 10.1039/x0xx00000x Title Author Full Name,*a Author Full Name b and Author Full Name c Abstract text goes here. The abstract should be a single paragraph that summarises the content of the article A Headings are the primary heading type e.g. Introduction, Results and discussion, Experimental B Headings should always be subordinate to A headings e.g. Synthetic procedures, Materials and methods, Crystallography. C headings should always be subordinate to B headings e.g. General procedure for synthesis of compound X. The main paragraph text follows directly on here. The main text of the article should appear here with headings as appropriate. Conclusions The conclusions section should come in this section at the end of the article, before the acknowledgements. Conflicts of interest In accordance with our policy on Conflicts of interest please ensure that a conflicts of interest statement is included in your manuscript here. Please note that this statement is required for all submitted manuscripts. If no conflicts exist, please state that “There are no conflicts to declare”. Acknowledgements The acknowledgements come at the end of an article after the conclusions and before the notes and references. Notes and references ? Footnotes relating to the main text should appear here. These might include comments relevant to but not central to the matter under discussion, limited experimental and spectral data, and crystallographic data. § §§ etc. Citations should appear here in the format A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523; A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523. …
SCI论文投稿经验！ 2009年，我代表本课题组共投递7篇SCI论文（主要是生殖和神经方向），分别投往IF2.5—10分的杂志，经历了许多坎坷。不过，现在可喜的是已经accept了5篇，均在3分左右，revised 了2篇。在修稿和投稿过程中，本人学习了不少相关知识和积累了一些经验，现与各位战友 分享，并请大家批评指正。 内容清单： 1、本人2009年SCI投稿经验总结（含SCI投稿程序） 2、本版众多投稿相关精华帖汇聚 3、众多战友的2009年投稿经历汇总 一、本人2009年SCI论文投稿步骤及其经验总结 （一）投稿程序 1、选择合适的SCI期刊-Choose a journal。结合专业知识、2008或2007年度影响因子 表和他人经验来综合选择要投递的期刊，并进入该期刊查询系统查询近年来的文章走向。 2、下载Introduction for submission。只要到每个杂志的首页，打开submit paper一栏，点击Introduction查看或下载即可。 3、稿件及其相关材料准备-Preparation：Manuscript.doc、Tables.doc、Figures.tiff（jpg 等）、Cover letter，有时还有Title page、Copyright agreement、Conflicts of interest等。 4、网上投稿-Submit a manuscript：先到每个杂志的首页，打开submit paper一栏，先 以通讯作者的身份register一个账号，然后以author login身份登录，按照提示依次完成：Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files，最后下载pdf，查看无误后，即可到投稿主页approve submission或直接submit it。 5、不定期关注稿件状态-Status：Submit New Manuscript、Submissions Sent Back to Author、Icomplete Submissions、Sbmissions Waiting for Author's Approval、Submissions Being Processed、Submissions Needing Revision、Rvisions Sent Back to Author、Icomplete Submissions Being Revised、Risions Waiting for Author's Approval、Revisions Being Processed、Declined Revisions。 6、修回稿的投递-Submitted the revised manuscript：主要修改revised manuscript、response to the reviewers、cover letter，还有其他修改的相关材料。程序是进入投稿主页main menu，点击revise，仍然按照原先程序投递（近似于4），切记把修改的标题、摘要和回复信等内容要修改。最后上传附件时，先把留下来且未修改的材料前打钩（表示留下不变），然 后点击next，再上传已经修改的材料（主要包括revised manuscript、response to the reviewers、cover letter等），最后下载pdf，查看无误后，即可到投稿主页approve submission或直接submit it。
一、投稿时的Cover latter 1). Here within enclosed is our paper for consideration to be published on "(Journal name)". The further information about the paper is in the following: The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere. I am the corresponding author and my address and other information is as follows: Address: Department of XXXXXXXXX, College of Chemistry and Enviromental Science, Henan Normal University Xinxiang City, Henan Province, 453007, P.R.China E-mail: Tel: +86-XXX-XXXXXXX Fax: +86-XXX-XXXXXXX Thank you very much for consideration! Sincerely Yours, Dr. XXX 2). Dear Dr. A: I am sending a manuscript entitled “ ” by – which I should like to submit for possible publication in the journal of - . Yours sincerely 3). Dear Dr. A: Enclosed is a manuscript entitled “” by sb, which we are submitting for publication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers. 4). Dear Dr. A: Please find enclosed for your review an origin al research article, “” by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source. We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. 二、询问有无收到稿件 Dear Editors, We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help.
Sample cover letter [Your Name] [Your Affiliation] [Your Address] [Date] Dear [Editor name], I/We wish to submit an original research article entitled “[title of article]” for consideration by [journal name]. I/We confirm that this work is original and has not been published elsewhere, nor is it currently under consideration for publication elsewhere. In this paper, I/we report on / show that _______. This is significant because __________. We believe that this manuscript is appropriate for publication by [journal name]because it… [specific re ference to the journal’s Aims & S cope]. __________. [Please explain in your own words the significance and novelty of the work, the problem that is being addressed, and why the manuscript belongs in this journal. Do not simply insert your abstract into your cover letter! Briefly describe the research you are reporting in your paper, why it is important, and why you think the readership of the journal would be interested in it.] We have no conflicts of interest to disclose. If you feel that the manuscript is appropriate for your journal, we suggest the following reviewers: [List reviewers and contact info, if requested by the journal] Please address all correspondence concerning this manuscript to me at [email address]. Thank you for your consideration of this manuscript. Sincerely, [Your name]